• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型抑制耐甲氧西林金黄色葡萄球菌(MRSA)的圆柱环芳烃的发散合成。

Divergent Synthesis of Novel Cylindrocyclophanes that Inhibit Methicillin-Resistant Staphylococcus aureus (MRSA).

机构信息

Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK.

Department of Biochemistry, University of Cambridge, Downing Site, Cambridge, CB2 1QW, UK.

出版信息

ChemMedChem. 2020 Jul 20;15(14):1289-1293. doi: 10.1002/cmdc.202000179. Epub 2020 Jun 12.

DOI:10.1002/cmdc.202000179
PMID:32424962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7522682/
Abstract

The cylindrocyclophanes are a family of macrocyclic natural products reported to exhibit antibacterial activity. Little is known about the structural basis of this activity due to the challenges associated with their synthesis or isolation. We hypothesised that structural modification of the cylindrocyclophane scaffold could streamline their synthesis without significant loss of activity. Herein, we report a divergent synthesis of the cylindrocyclophane core enabling access to symmetrical macrocycles by means of a catalytic, domino cross-metathesis-ring-closing metathesis cascade, followed by late-stage diversification. Phenotypic screening identified several novel inhibitors of methicillin-resistant Staphylococcus aureus. The most potent inhibitor has a unique tetrabrominated [7,7]paracyclophane core with no known counterpart in nature. Together these illustrate the potential of divergent synthesis using catalysis and unbiased screening methods in modern antibacterial discovery.

摘要

筒环芳烃是一类具有报道抗菌活性的大环天然产物。由于其合成或分离的挑战性,对其活性的结构基础知之甚少。我们假设对筒环芳烃支架的结构修饰可以简化其合成,而不会显著降低其活性。在此,我们报告了一种筒环芳烃核心的发散合成方法,通过催化的、串联的交叉复分解-关环复分解级联反应,以获得对称的大环,然后进行后期的多样化。表型筛选鉴定出几种新型耐甲氧西林金黄色葡萄球菌抑制剂。最有效的抑制剂具有独特的四溴化[7,7]并环芳烃核心,在自然界中没有已知的对应物。这些共同说明了在现代抗菌药物发现中使用催化和无偏筛选方法进行发散合成的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e5/7522682/c34afdf8ce7d/CMDC-15-1289-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e5/7522682/1495032dfbd1/CMDC-15-1289-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e5/7522682/645054f0c758/CMDC-15-1289-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e5/7522682/494c823ae05f/CMDC-15-1289-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e5/7522682/20ff7c1e9d2f/CMDC-15-1289-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e5/7522682/c34afdf8ce7d/CMDC-15-1289-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e5/7522682/1495032dfbd1/CMDC-15-1289-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e5/7522682/645054f0c758/CMDC-15-1289-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e5/7522682/494c823ae05f/CMDC-15-1289-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e5/7522682/20ff7c1e9d2f/CMDC-15-1289-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e5/7522682/c34afdf8ce7d/CMDC-15-1289-g002.jpg

相似文献

1
Divergent Synthesis of Novel Cylindrocyclophanes that Inhibit Methicillin-Resistant Staphylococcus aureus (MRSA).新型抑制耐甲氧西林金黄色葡萄球菌(MRSA)的圆柱环芳烃的发散合成。
ChemMedChem. 2020 Jul 20;15(14):1289-1293. doi: 10.1002/cmdc.202000179. Epub 2020 Jun 12.
2
Total Synthesis of Berkeleylactone A.Berkeleylactone A 的全合成。
J Org Chem. 2019 Jun 7;84(11):7159-7165. doi: 10.1021/acs.joc.9b00850. Epub 2019 May 23.
3
3-Hydroxy-1,5-dihydro-2H-pyrrol-2-ones as novel antibacterial scaffolds against methicillin-resistant Staphylococcus aureus.3-羟基-1,5-二氢-2H-吡咯-2-酮作为抗耐甲氧西林金黄色葡萄球菌的新型抗菌骨架
Bioorg Med Chem Lett. 2018 Sep 1;28(16):2732-2735. doi: 10.1016/j.bmcl.2018.02.047. Epub 2018 Feb 27.
4
Total synthesis and biological evaluation of the antibiotic lysocin E and its enantiomeric, epimeric, and N-demethylated analogues.抗生素 lysocin E 及其对映异构体、差向异构体和 N-去甲基类似物的全合成及生物评价。
Angew Chem Int Ed Engl. 2015 Jan 26;54(5):1556-60. doi: 10.1002/anie.201410270. Epub 2014 Dec 11.
5
Random peptide mixtures inhibit and eradicate methicillin-resistant Staphylococcus aureus biofilms.随机肽混合物可抑制并根除耐甲氧西林金黄色葡萄球菌生物膜。
Chem Commun (Camb). 2016 Jun 4;52(44):7102-5. doi: 10.1039/c6cc01438k. Epub 2016 May 10.
6
Riccardin C derivatives as anti-MRSA agents: structure-activity relationship of a series of hydroxylated bis(bibenzyl)s.Riccardin C 衍生物作为抗耐甲氧西林金黄色葡萄球菌(MRSA)药物:一系列羟基化双(联苄基)类化合物的结构-活性关系。
Bioorg Med Chem Lett. 2012 Dec 15;22(24):7444-7. doi: 10.1016/j.bmcl.2012.10.052. Epub 2012 Oct 17.
7
Synthesis and antibacterial evaluation of a novel library of 2-(thiazol-5-yl)-1,3,4-oxadiazole derivatives against methicillin-resistant Staphylococcus aureus (MRSA).合成并评价新型 2-(噻唑-5-基)-1,3,4-恶二唑类衍生物库对耐甲氧西林金黄色葡萄球菌(MRSA)的抗菌活性。
Bioorg Chem. 2020 Jan;94:103364. doi: 10.1016/j.bioorg.2019.103364. Epub 2019 Oct 18.
8
Simple synthesis of endophenazine G and other phenazines and their evaluation as anti-methicillin-resistant Staphylococcus aureus agents.内吩嗪 G 及其他吩嗪的简便合成及其作为抗耐甲氧西林金黄色葡萄球菌药物的评价。
Eur J Med Chem. 2017 Jan 5;125:710-721. doi: 10.1016/j.ejmech.2016.09.079. Epub 2016 Sep 28.
9
Design, synthesis, and evaluation of N,N-dialkyldioxonaphthoimidazoliums as antibacterial agents against methicillin-resistant Staphylococcus aureus.设计、合成和评估 N,N-二烷基二氧萘并咪唑𬭩盐作为抗耐甲氧西林金黄色葡萄球菌的抗菌剂。
Eur J Med Chem. 2024 Jun 5;272:116454. doi: 10.1016/j.ejmech.2024.116454. Epub 2024 May 4.
10
In vitro and in vivo evaluation of novel ursolic acid derivatives as potential antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA).新型熊果酸衍生物作为抗耐甲氧西林金黄色葡萄球菌(MRSA)潜在抗菌剂的体外和体内评价
Bioorg Chem. 2025 Jan;154:107986. doi: 10.1016/j.bioorg.2024.107986. Epub 2024 Nov 22.

引用本文的文献

1
Ligand-Metal Cooperation Enables Net Ring-Opening C-C Activation / Difunctionalization of Cyclopropyl Ketones.配体-金属协同作用实现环丙基酮的净开环C-C活化/双官能化
ACS Catal. 2023 Sep 1;13(17):11277-11290. doi: 10.1021/acscatal.3c02643. Epub 2023 Aug 11.

本文引用的文献

1
Chemistry, bioactivity and biosynthesis of cyanobacterial alkylresorcinols.蓝细菌烷基间苯二酚的化学、生物活性和生物合成。
Nat Prod Rep. 2019 Oct 16;36(10):1437-1461. doi: 10.1039/c8np00080h.
2
Total Synthesis of (-)-Cylindrocyclophane F: A Yardstick for Probing New Catalytic C-C Bond-Forming Methodologies.(-)-Cylindrocyclophane F 的全合成:探索新型催化 C-C 键形成方法的基准。
Chemistry. 2018 Nov 13;24(63):16770-16773. doi: 10.1002/chem.201804585. Epub 2018 Oct 22.
3
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
发现、研究和开发新抗生素:世界卫生组织抗微生物药物耐药性和结核病优先病原体清单。
Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21.
4
Gram-Scale Synthesis and Highly Regioselective Bromination of 1,1,9,9-Tetramethyl[9](2,11)teropyrenophane.克级规模合成及 1,1,9,9-四甲基[9](2,11)并苝二萘嵌苯的高区域选择性溴化
Angew Chem Int Ed Engl. 2018 Feb 5;57(6):1707-1711. doi: 10.1002/anie.201713067. Epub 2018 Jan 16.
5
Modular Synthesis of Diverse Natural Product-Like Macrocycles: Discovery of Hits with Antimycobacterial Activity.多样类天然产物大环化合物的模块化合成:具有抗分枝杆菌活性的活性化合物的发现
Chemistry. 2017 May 29;23(30):7207-7211. doi: 10.1002/chem.201701150. Epub 2017 May 2.
6
Merocyclophanes C and D from the Cultured Freshwater Cyanobacterium Nostoc sp. (UIC 10110).从培养的淡水蓝藻念珠藻属(UIC 10110)中分离得到的半环番C和D。
J Nat Prod. 2017 Apr 28;80(4):1073-1080. doi: 10.1021/acs.jnatprod.6b01175. Epub 2017 Mar 2.
7
Antibiotics in the clinical pipeline at the end of 2015.2015年末处于临床研发阶段的抗生素
J Antibiot (Tokyo). 2017 Jan;70(1):3-24. doi: 10.1038/ja.2016.72. Epub 2016 Jun 29.
8
Synthesis of riccardin D derivatives as potent antimicrobial agents.作为强效抗菌剂的瑞卡汀D衍生物的合成。
Bioorg Med Chem Lett. 2016 Aug 1;26(15):3617-20. doi: 10.1016/j.bmcl.2016.06.006. Epub 2016 Jun 4.
9
A platform for the discovery of new macrolide antibiotics.一个用于发现新型大环内酯类抗生素的平台。
Nature. 2016 May 19;533(7603):338-45. doi: 10.1038/nature17967.
10
Effects of Halide Ions on the Carbamidocyclophane Biosynthesis in Nostoc sp. CAVN2.卤离子对念珠藻属CAVN2中碳酰胺环烷生物合成的影响
Mar Drugs. 2016 Jan 20;14(1):21. doi: 10.3390/md14010021.